Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses recommended approaches to monitor and treat infections in patients with multiple myeloma treated with bispecific T-cell engagers (BiTEs). Dr Raje also discusses which prophylaxis regimens should be used for these patients. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.